Outcomes of Late-Onset Bleb-Related Endophthalmitis Treated with Pars Plana Vitrectomy
Table 3
Comparison with or without highly pathogenic bacteria.
HPB ()
Without HPB ()
value
Age (year, mean ± SD)
65.8 ± 10.7
45.5 ± 12.5
.0349
Male/female
3/3
2/3
1.0000
Right/left
1/5
1/4
1.0000
Median value before BRE
0.46
0.15
.3131
Median value after PPV
4.0
0.7
.0337
IOP before BRE (mmHg, mean ± SD)
7.7 ± 3.3
11.0 ± 2.3
.0541
IOP after PPV (mmHg, mean ± SD)
9.2 ± 7.4
16.8 ± 8.9
.3591
Follow-up period after BRE (year, mean ± SD)
4.7 ± 2.8
1.7 ± 1.1
.0828
Period between trabeculectomy and BRE onset (year, mean ± SD)
7.2 ± 5.3
7.8 ± 5.5
.7832
PSITE (day, mean ± SD)
2.7 ± 2.3
1.5 ± 1.7
.6427
Bleb leakage (when BRE occurred)
3
4
.5455
Bleb location (superior/inferior)
5/1
5/0
1.0000
Lens condition (with phakia/without phakia)
3/3
2/3
1.0000
Diabetes mellitus
1
1
1.0000
Connective tissue disease
2
0
.4545
Oral administration of corticosteroids
1
0
1.0000
Previous trabeculectomy (time, mean ± SD)
1.5 ± 0.5
1.4 ± 0.9
.5925
Previous intraocular surgery (time, mean ± SD)
1.8 ± 1.0
2.6 ± 1.1
.2911
Bleb removal and conjunctival advancement
6
5
1.0000
PPV with LASER treatment
5
1
.0801
Wilcoxon’s signed-rank test. Without phakia means pseudophakia or aphakia. HPB = highly pathogenic bacteria, SD = standard deviation, BRE = bleb-related endophthalmitis, PPV = pars plana vitrectomy, IOP = intraocular pressure, and PSITE = the periods from starting symptom to initiation of treatment for endophthalmitis.
